Anemia is a debilitating condition that causes significant morbidity and mortality. It is a common condition caused by multiple etiologies and has a significant negative impact on quality of life. In the clinic, treatments for anemia are designed to raise hemoglobin levels and improve oxygen delivery to the tissues. Recent work, however, suggests that the primary therapies for anemia, transfusion therapy and treatment with recombinant erythropoietin (Epo), can themselves cause pathology. These observations underscore the need to develop new, effective long term therapies to treat anemia. In healthy individuals, the bone marrow constantly generates new erythrocytes to replaced worn out cells. This process is referred to as steady state erythropoiesis. In response to anemic challenge, the situation is different. Tissue hypoxia initiates a physiological response designed to increase oxygen delivery to the tissues. At these times stress erythropoiesis predominates. Most of what we know about stress erythropoiesis comes from the study of murine stress erythropoiesis. It is an extramedullary process that takes place in the fetal liver during development and the adult spleen and liver. Stress erythropoiesis utilizes a specialized population of erythroid progenitors that are distinct from steady state progenitors in that they can rapidly generate large numbers of new erythrocytes. Stress erythropoiesis is regulated by signals not associated with steady state erythropoiesis. Our previous work identified a population of stress erythroid progenitors that exhibit stem cell properties. These cells could be serially transplanted into irradiated mice, where they maintained erythropoiesis without contribution to other lineages until surviving stem cells could repopulate the mouse. The transplanted stress erythroid progenitors establish a durable stress response compartment that can then respond to subsequent anemic challenges. Thus a better understanding of the mechanisms that regulate stress erythropoiesis will identify new targets for therapeutic intervention. In this proposal, we outline experiments designed to understand the mechanisms that regulate the expansion of immature stress erythroid progenitors and the signals that promote their differentiation as these regulatory points represent transitions in the pathway that could be exploited in the development of new therapies for anemia.
In Aim 1, we will investigate the mechanism by which signals from the microenvironment regulate the expansion of immature stem cell like stress progenitors. Macrophages are key components of the stress erythroid microenvironment. In the second aim, we will examine how Epo alters the macrophage microenvironment by inhibiting the production of signals that promote expansion and self-renewal and activating signals that promote differentiation. In the final aim, we will examine the mechanism by which differentiation signals generated by macrophages promote the transition from amplifying stress erythroid progenitors to differentiating stress erythroid progenitors.

Public Health Relevance

Anemia is a debilitating condition that has a significant negative impact on quality of life. Anemia results in less oxygen delivered to tissues. This situation induces a physiological response to boost oxygen delivery to the tissues. We have identified a key component of this response which rapidly increases the production of new erythrocytes at times of acute need. In this proposal we seek further characterize this response and identify potential targets for therapeutic intervention to treat anemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK080040-05A1
Application #
8697179
Study Section
Molecular and Cellular Hematology (MCH)
Program Officer
Bishop, Terry Rogers
Project Start
2007-12-01
Project End
2018-03-31
Budget Start
2014-05-15
Budget End
2015-03-31
Support Year
5
Fiscal Year
2014
Total Cost
$311,223
Indirect Cost
$93,723
Name
Pennsylvania State University
Department
Veterinary Sciences
Type
Schools of Earth Sciences/Natur
DUNS #
003403953
City
University Park
State
PA
Country
United States
Zip Code
16802
Xiang, Jie; Wu, Dai-Chen; Chen, Yuanting et al. (2015) In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors. Blood 125:1803-12
Gandhi, Ujjawal H; Kaushal, Naveen; Hegde, Shailaja et al. (2014) Selenium suppresses leukemia through the action of endogenous eicosanoids. Cancer Res 74:3890-901
Paulson, Robert F (2014) Targeting a new regulator of erythropoiesis to alleviate anemia. Nat Med 20:334-5
Hegde, Shailaja; Hankey, Pamela; Paulson, Robert F (2012) Self-renewal of leukemia stem cells in Friend virus-induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling but not mutation of p53. Stem Cells 30:121-30
Anderson, Nicole M; Berberovic, Zorana; Berndl, Elizabeth et al. (2012) Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens. Exp Hematol 40:48-60
Hegde, Narasimha V; Unger, Erica L; Jensen, Gordon L et al. (2011) Interrelationships between tissue iron status and erythropoiesis during postweaning development following neonatal iron deficiency in rats. Am J Physiol Gastrointest Liver Physiol 300:G470-6
Paulson, Robert F; Shi, Lei; Wu, Dai-Chen (2011) Stress erythropoiesis: new signals and new stress progenitor cells. Curr Opin Hematol 18:139-45
Kaushal, Naveen; Hegde, Shailaja; Lumadue, Jeanne et al. (2011) The regulation of erythropoiesis by selenium in mice. Antioxid Redox Signal 14:1403-12
Gandhi, Ujjawal H; Kaushal, Naveen; Ravindra, Kodihalli C et al. (2011) Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. J Biol Chem 286:27471-82
Hughes, Michael R; Anderson, Nicole; Maltby, Steven et al. (2011) A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis. Exp Hematol 39:305-20, 320.e1-2

Showing the most recent 10 out of 15 publications